HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Feline Lymphoma

Feline Lymphoma

Feline lymphoma poses a complex challenge within veterinary oncology, warranting extensive research efforts. Investigations delve into various aspects of the disease, including its origins, progression mechanisms, and therapeutic interventions. Scientists explore potential genetic susceptibilities, environmental influences, and viral triggers such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Cutting-edge imaging technologies aid in early detection, while innovative treatments like chemotherapy, radiation, and immunotherapy offer hope for better outcomes. Furthermore, clinical trials evaluate promising drugs and targeted therapies tailored specifically for feline lymphoma. Through these multifaceted endeavors, researchers aim to deepen our understanding of the condition, refine diagnostic approaches, and advance treatment modalities, ultimately enhancing the well-being of cats affected by this ailment.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Ahora Chehri

Ahora Chehri

Johann Wolfgang Goethe Universität Frankfurt am, Germany
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Ratan Kumar Sarkar

Ratan Kumar Sarkar

Independent Researcher, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp
Feline Lymphoma | Cancer & Immuno-Oncology Conference